Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | GDC-0941 | gCSI | pan-cancer | AAC | 0.0053 | 0.9 |
mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | 0.0038 | 0.9 |
mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.0026 | 1 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |